Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

Medical Xpress

A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers.

The research found that GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide (brand names: Ozempic, Wegovy) and tirzepatide (brand names: Mounjaro and Zepbound), were associated with a 41% decrease in the overall risk of developing cancer among non-diabetic patients who used the drugs for weight management, compared to those who relied on diet and exercise alone. ...

전문 보기

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

관련 뉴스

'science' 카테고리 뉴스

M 6.5 - 19 km SW of Balangonan, Philippines

Mysterious signals keep coming from space: Astronomers find their 'Rosetta stone'

A good night's sleep begins with healthy gut bacteria. Here's how to look after yours

Medical Xpress의 다른 기사

CAR-T cells enhanced with navigation system to penetrate lymph nodes more efficiently

Newly discovered view of brain blood flow during surgery could prevent debilitation, save lives

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery